Real-time treatment monitoring for electroporation ablation
This technology is a smarter electroporation system — a medical tool that uses electrical pulses to destroy unwanted tissue, such as tumors. What makes it distinctive is that it continuously monitors its own progress in real time by sending high-frequency test signals (at least 1 MHz) into the tissue and measuring how its electrical resistance changes. As the tissue is being treated, the system tracks these impedance shifts to tell the clinician exactly how far along the procedure is and when to stop — without guessing or relying on fixed time limits. This replaces a largely blind process with a feedback-driven one.
What you could build
A capital medical device — either a standalone pulse generator system or an upgrade module for existing electroporation platforms — sold to interventional oncology and cardiac electrophysiology labs that perform irreversible electroporation (IRE) procedures. Buyers would be hospital systems and procedural centers using devices like NanoKnife.
Who in Virginia should care
Virginia's academic medical centers (UVA Health, Inova) and med-tech device companies in the Northern Virginia/DC corridor would be natural early adopters or licensing partners for procedural oncology tools.
Readiness: Lab validated
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- —
- Granted
- March 26, 2019
- Status
- Granted patent
- Patent number
- 102841
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.